News Daily News Early Coronary Heart Disease Linked to Later Dementia, Alzheimer’s Michael O'Riordan November 29, 2023
News Daily News FDA Approves Paradise Renal Denervation System: What Comes Next? Todd Neale November 08, 2023
News Conference News TCT 2023 RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months Todd Neale October 31, 2023
News Daily News PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY Michael O'Riordan September 29, 2023
News Daily News As Renal Denervation Heads to Advisory Review, FDA Sets Out Key Questions L.A. McKeown August 18, 2023
News Daily News Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death Michael O'Riordan July 07, 2023
News Daily News PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains Shelley Wood June 22, 2023
News Daily News Tight Link Between Ambulatory BP and Mortality Affirmed in Revamped Analysis Todd Neale May 10, 2023
News Daily News Low-Dose Polypills Top Other Approaches for Initial BP Control: Meta-analysis Todd Neale April 26, 2023
News Daily News Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows L.A. McKeown April 12, 2023
News Daily News Third-Trimester Preeclampsia Screening Still Worthwhile, Data Suggest Caitlin E. Cox April 11, 2023
News Daily News Brain Areas Identified Linking High BP and Cognitive Impairment Todd Neale March 31, 2023
News Conference News ACC 2023 Diabetic Patients in Middle East, Africa Overburdened by ASCVD Michael O'Riordan March 14, 2023
News Conference News ACC 2023 HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension Todd Neale March 08, 2023
News Conference News CRT 2023 Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months Yael L. Maxwell February 28, 2023
News Daily News Longer-Term ASCVD Risk Assessment Best for Younger Patients Michael O'Riordan February 16, 2023